0001127602-13-034708.txt : 20131216
0001127602-13-034708.hdr.sgml : 20131216
20131216163007
ACCESSION NUMBER: 0001127602-13-034708
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131212
FILED AS OF DATE: 20131216
DATE AS OF CHANGE: 20131216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERRIGO CO
CENTRAL INDEX KEY: 0000820096
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 382799573
STATE OF INCORPORATION: MI
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
BUSINESS PHONE: 2696738451
MAIL ADDRESS:
STREET 1: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAPA JOSEPH C
CENTRAL INDEX KEY: 0001242215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09689
FILM NUMBER: 131279239
MAIL ADDRESS:
STREET 1: C/O WATSON PHARMACEUTICALS INC
STREET 2: 311 BONNIE CIRCLE
CITY: CORONA
STATE: CA
ZIP: 92880
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-12-12
0000820096
PERRIGO CO
PRGO
0001242215
PAPA JOSEPH C
C/O PERRIGO COMPANY
515 EASTERN AVENUE
ALLEGAN
MI
49010
1
1
1
President and CEO
Chairman
Common Stock
2013-12-12
4
M
0
3963
35.85
A
120618
D
Common Stock
2013-12-12
4
S
0
3963
150.2179
D
116655
D
Common Stock
2013-12-12
4
M
0
2186
30.06
A
118841
D
Common Stock
2013-12-12
4
S
0
2186
150.4851
D
116655
D
Common Stock
2013-12-12
4
M
0
8851
58.82
A
125506
D
Common Stock
2013-12-12
4
S
0
1164
149.4278
D
124342
D
Common Stock
2013-12-12
4
S
0
7687
150.073
D
116655
D
Common Stock
2013-12-09
5
G
0
E
20000
0
D
96655
D
Employee Stock Option Right to Buy
35.85
2013-12-12
4
M
0
3963
0
D
2018-08-25
Common Stock
3963
0
D
Employee Stock Option Right to Buy
30.06
2013-12-12
4
M
0
2186
0
D
2010-08-25
2019-08-25
Common Stock
2186
0
D
Employee Stock Option Right to Buy
58.82
2013-12-12
4
M
0
8851
0
D
2020-08-19
Common Stock
8851
30183
D
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 11, 2013. This 10b5-1 sales plan will expire on the close of business November 11, 2014.
The price in column 4 is a weighted average. The prices actually received ranged from $149.85 to $150.61. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $150.28 to $150.68. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $149.37 to $149.465. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $149.48 to $150.47. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Exercisable in 3 equal annual installments beginning 8/25/09.
Exercisable in 3 equal annual installments beginning 8/19/11.
/s/ Penny Bursma, Attorney-in-fact for Joseph C. Papa
2013-12-16